Cargando…

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail

A discussion of two landmark papers highlighting the use of spirometry as a sensitive measure of the rate of decline in FEV(1) in COPD, and the importance of using the Global Lung Function Initiative reference data http://bit.ly/2C0Nhqa

Detalles Bibliográficos
Autores principales:	Kirkby, Jane, Nenna, Raffaella, McGowan, Aisling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885335/ https://www.ncbi.nlm.nih.gov/pubmed/31803269 http://dx.doi.org/10.1183/20734735.0252-2019

Ejemplares similares

When to refer patients with advanced COPD to palliative care services
por: Strutt, Rebecca
Publicado: (2020)

The treatment of acute bronchiolitis: past, present and future
por: Petrarca, Laura, et al.
Publicado: (2017)

Early ward-based acute noninvasive ventilation: a paper that changed practice
por: Mukherjee, Rahul, et al.
Publicado: (2018)

Will an electronic nose help at high altitude?
por: Vinnikov, Denis, et al.
Publicado: (2018)

Novel therapies for severe asthma in children and adults
por: Delimpoura, Vasiliki, et al.
Publicado: (2018)

Asbestos and the lung: highlights of a detrimental relationship
por: Iliopoulou, Marianthi, et al.
Publicado: (2017)

From research question to dissemination: how to design, analyse and present study results
por: Fasola, Salvatore, et al.
Publicado: (2018)

The era of CFTR modulators: improvements made and remaining challenges
por: Cuevas-Ocaña, Sara, et al.
Publicado: (2020)

Noninvasive ventilation in hypercapnic respiratory failure: from rocking beds to fancy masks
por: Schreiber, Annia, et al.
Publicado: (2018)

To sleep, or not to sleep – that is the question, for polysomnography
por: Corlateanu, Alexandru, et al.
Publicado: (2017)

Fate plasticity in the intestine: The devil is in the detail
por: Buczacki, Simon
Publicado: (2019)

Zooming in on the ERS fellowships and the International Congress
por: Nenna, Raffaella, et al.
Publicado: (2018)

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
por: Long, Gabriella, et al.
Publicado: (2018)

New members of the ECMC and lessons from the ATS Conference
por: Alfaro, Tiago M., et al.
Publicado: (2018)

Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
por: McDonnell, Melissa J., et al.
Publicado: (2021)

Treatable Traits in COPD – A Proposed Approach
por: Cardoso, João, et al.
Publicado: (2021)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
por: Recio Iglesias, Jesús, et al.
Publicado: (2020)

Initial inhaler choice in COPD: real-world evidence
por: Jones, Thomas
Publicado: (2019)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2022)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications?
por: van den Berge, Maarten, et al.
Publicado: (2016)

Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry
por: Capstick, Toby G D, et al.
Publicado: (2021)

Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus
por: Miravitlles, Marc, et al.
Publicado: (2023)

Putting lung function reference equations into context
por: Borg, Brigitte M., et al.
Publicado: (2021)

Contrasting the physiological effects of heliox and oxygen during exercise in a patient with advanced COPD
por: Louvaris, Zafeiris, et al.
Publicado: (2019)

Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
por: Adepoju, Victor A.
Publicado: (2019)

Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness
por: Janssen, Daisy J.A., et al.
Publicado: (2019)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
por: Singh, Dave, et al.
Publicado: (2021)

Early Career Members at the ERS International Congress 2017: highlights from the Assemblies
por: Kahn, Nicolas, et al.
Publicado: (2017)

The importance of screening in children who snore
por: Evangelisti, Melania, et al.
Publicado: (2019)

The devil's in the details
por: Petsko, Gregory A
Publicado: (2010)

Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation
por: Toraldo, Domenico Maurizio, et al.
Publicado: (2011)

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals
por: Gaduzo, S, et al.
Publicado: (2019)

Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
por: Franssen, Frits M.E., et al.
Publicado: (2019)

Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications
por: van Loghem, Jani, et al.
Publicado: (2021)

Bronchodilator response cut-off points and FEV (0.75) reference values for spirometry in preschoolers
por: Burity, Edjane Figueiredo, et al.
Publicado: (2016)

Situational judgment tests reliably measure professional attributes important for clinical practice
por: Petty-Saphon, Katie, et al.
Publicado: (2016)

Commentary: The devil is in the details
por: Falasa, Matheus P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tapgdfvnm7925p4sriqnu8kq7p